Modality.AI
Modality.ai provides multimodal technology for the objective assessment of CNS conditions through automated speech and visual analytics of conversations elicited by Tina, a virtual guide. Our platform is used in clinic and remotely in IRB approved studies generating over 20,000 recorded sessions to date. Modality is led by a team of world-class scientists, clinicians, technologists, and serial entrepreneurs, and has shown clinical validation through numerous peer-reviewed publications.
Company Overview
Modality.AI is a small business founded in 2018, located in San Francisco, California. The company operates within the Hospital & Health Care industry, specializing in self-driven neurological assessments. With a team size of 30, Modality.AI focuses on leveraging advanced technologies such as artificial intelligence, natural language processing, and machine learning to enhance health technology solutions.
Technological Innovations
Modality.AI has developed an automated, clinically validated multimodal system designed to assess neurological and psychiatric states both in clinical settings and remotely. The platform utilizes automated speech and visual analytics through a virtual guide named Tina. It is compatible with computers, tablets, and smartphones, requiring only a browser, webcam, and microphone for operation.
Clinical Applications
The platform is utilized to assess various neurological and psychiatric conditions, including ALS, Parkinson’s disease, and depression. Modality.AI has a pipeline that includes additional conditions such as autism, Huntington's disease, schizophrenia, and mild cognitive impairment. The system is recognized as a Class II medical device by the FDA and is HIPAA-compliant, enabling home monitoring without the need for special software.
Research and Collaboration
Modality.AI has demonstrated clinical validation through over 100 peer-reviewed publications and has generated more than 20,000 recorded sessions through IRB-approved studies. The company collaborates with esteemed institutions, including UCSF, Massachusetts General Hospital, and Charité in Germany, focusing on advancing research in neurological and mental health conditions.
Funding and Community Engagement
Modality.AI received a $2.3 million grant from the NIH to support research on ALS. The company is actively involved in the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society, emphasizing its commitment to patient-centric data collection through the integration of the Patient Report of Problems (PROP) into its platform.